Latest Clinical Studies for Anti-Aging Products Test for Efficacy in Skin-care Ingredients for Affordable Skin Formulations
CORAL SPRINGS, Florida, October 9, 2014 /PRNewswire/ --
Skin-Care developments and extensive Clinical Trials advancements in the Anti-Aging Industry have lead to robust gains within Personal Products Sector. Companies in focus today are: Technology Applications International Corporation (OTCBB: NUUU), Coty Inc. (NYSE: COTY), Nu Skin Enterprises Inc. (NYSE: NUS), Elizabeth Arden, Inc. (NASDAQ: RDEN) and The Procter & Gamble Company (NYSE: PG)
Technology Applications International Corporation (OTCQB: NUUU) announced today that they concluded a clinical study to test the efficacy of its wholly owned subsidiary's Rejuvel Line of Anti-Aging Products that use NASA* Patented Technology at Essex Testing Clinic in Verona, NJ. The Essex Testing Clinic staff includes PhDs, nurses, clinical study, quality assurance and recruitment professionals, trained evaluators and a large network of consulting physicians, all of whom have extensive experience in clinical investigation. Essex personnel visually evaluated facial imperfections of each subject. In addition, scientific measurements were taken to measure the firmness and elasticity of the skin to detect change.
The results were outstanding. 100% of the participants showed real and noticeable facial skin improvements. To read the full NUUU press release along with details from the Participants, please click here: http://www.financialnewsmedia.com/profiles/nuuu.html
Charles J. Scimeca, NUUU's CEO stated, "The conclusion of this clinical study fulfills the requirements to be able to broadcast on home shopping channels, such as the three major networks, Home Shopping Network, NASDAQ trading symbol "HSNI," QVC, owned by Liberty Interactive Corporation, NASDAQ trading symbol "LINTA," and ShopHQ, a subsidiary of ValueVision Media, NASDAQ trading symbol "VVTV." Our next step is to voluntarily submit our testing claims to the Federal Drug Administration (FDA)." * Licensed from the National Aeronautics and Space Administration and Administrators of the Tulane Educational Fund under U.S. Patent No. 6,730,498
Coty Inc. (NYSE: COTY) and CHANEL recently announced that Coty has submitted a binding offer to acquire the Bourjois cosmetics brand from CHANEL for 15 million Class A Coty shares. CHANEL has agreed to enter into exclusive negotiations. Bourjois' portfolio of color cosmetic products are sold through approximately 23,000 points of sale in more than 50 countries around the world, enjoying leading positions in some of the most attractive markets for color cosmetics, such as Western Europe, the Middle East and Asia. Bourjois was founded in 1863, by French actor Joseph-Albert Ponsin, who developed a line of color cosmetics for his fellow actors. "We are looking forward to having the Bourjois brand as part of our portfolio of leading beauty products, as well as welcoming CHANEL as a Coty shareholder," said Bart Becht, Chairman and Interim CEO of Coty Inc.
Nu Skin Enterprises Inc. (NYSE: NUS) develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex brands. It offers skin-care systems and treatment products, including ageLOC Galvanic Spa System, ageLOC Galvanic Body Spa, and ageLOC Transformation anti-aging skin care system, as well as other cosmetic, personal, and hair care products. The company also provides ageLOC TR90 weight management and body shaping systems; LifePak; ageLOC R2 nutritional supplement; and ageLOC transformation daily skin care system. It is involved in the research and product development of aging, including the influence of certain ingredients on gene expression. On Wednesday, NUS closed up 1.43% on over 1.5 million shares traded.
Elizabeth Arden, Inc. (NASDAQ: RDEN), a beauty products company, Elizabeth Arden's fundamental belief was that beauty should not be a veneer of makeup, but an intelligent cooperation between science and nature in order to develop a woman's finest natural assets. She lived by her mantra, "To be beautiful is the birthright of every woman." Miss Arden created skin care products that benefited, not masked, the skin. She not only promoted her concept of Total Beauty, including diligent skincare, nutrition and fitness, but lived it prudently as she persistently sought to bring a scientific approach to skincare formulations. RDEN closed up 3.89% on Wednesday with a volume of over 400,000.
In other health products news - The Procter & Gamble Company (NYSE: PG) was recently honored for the critical role P&G's partners have played in the Company's efforts to provide safe drinking water and help save lives around the world. The P&G Children's Safe Drinking Water Program (CSDW), which is celebrating its 10th anniversary in 2014, and the Pampers UNICEF campaign to eliminate maternal and newborn tetanus, were the two programs highlighted with specific focus on the roles of CSDW partners AmeriCares and ChildFund and Pampers UNICEF partner Tesco, for their contributions to saving thousands of lives.
FinancialNewsMedia.com is a leading provider of third party publishing & news dissemination services. If you would like more information regarding our news coverage solutions, please visit http://www.financialnewsmedia.com for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at http://www.financialnewsmedia.com/. Follow us on Facebook: http://www.facebook.com/financialnewsmedia and Twitter: http://twitter.com/FNMgroup.
DISCLAIMER: FN Media Group LLC (FNMG) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNMG is NOT affiliated in any manner with any company mentioned herein. FNMG and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNMG has been compensated one thousand five hundred dollars for news coverage of the current press release issued by Technology Applications International Corporation by the company. FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.
Contact Information:
Company: FN Media Group, LLC
Contact email: [email protected]
U.S. Phone: +1(954)345-0611
URL: http://www.financialnewsmedia.com
SOURCE FN Media Group, LLC
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article